The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sustained MRD negativity in patients with newly diagnosed multiple myeloma treated with carfilzomib-lenalidomide-dexamethasone with or without isatuximab (phase III IsKia trial).
 
Francesca Gay
Honoraria - AbbVie; Amgen; Bristol Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Sanofi; Takeda
Consulting or Advisory Role - AbbVie; Amgen; AstraZeneca; Bristol Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Kite, a Gilead company; Oncopeptides; Pfizer; Roche; Sanofi; Takeda
 
Wilfried Roeloffzen
Honoraria - Janssen-Cilag (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Janssen-Cilag (Inst); Sanofi (Inst)
 
Meletios Dimopoulos
Honoraria - Amgen; AstraZeneca; Beigene; Bristol-Myers Squibb; GlaxoSmithKline; Janssen-Cilag; Menarini; Regeneron; Sanofi; Swixx BioPharma; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Beigene; Bristol-Myers Squibb; GlaxoSmithKline; Janssen-Cilag; Menarini; Regeneron; Sanofi; Swixx BioPharma; Takeda
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb/Celgene; Janssen; Takeda
 
Laura Rosiñol
Honoraria - Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Bristol Myers Squibb Foundation; GlaxoSmithKline; Janssen-Cilag; Sanofi; Takeda
 
Marjolein van der Klift
No Relationships to Disclose
 
Albert Oriol
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Pfizer; Sanofi
Speakers' Bureau - Amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Sanofi
 
Eirini Katodritou
Honoraria - Amgen; Johnson & Johnson; Sanofi; Takeda
Research Funding - AbbVie; Amgen; Johnson & Johnson; Karyopharm Therapeutics; Pfizer; Sanofi; Takeda
 
Ka-Lung Wu
Consulting or Advisory Role - Janssen; Janssen Oncology; Sanofi
Travel, Accommodations, Expenses - sonofie
 
Paula Rodríguez-Otero
Honoraria - Abbvie; Celgene; GlaxoSmithKline; H3 Biomedicine; Janssen; Pfizer; Regeneron; Roche/Genentech; Sanofi
Consulting or Advisory Role - Abbvie; BMS; GlaxoSmithKline; Janssen; Pfizer; Roche; Sanofi
Speakers' Bureau - BMS; GlaxoSmithKline; Janssen; Sanofi
Travel, Accommodations, Expenses - Pfizer
 
Roman Hajek
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Takeda
Consulting or Advisory Role - AbbVie; Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; PharmaMar; Takeda
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Janssen (Inst); Novartis (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - AbbVie; Amgen; Celgene; Janssen; Takeda
 
Elena M. van Leeuwen-Segarceanu
No Relationships to Disclose
 
Elena Zamagni
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Menarini Group; Oncopeptides; Pfizer; Sanofi
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Menarini Group; Oncopeptides; Pfizer; Sanofi
 
Niels van de Donk
Consulting or Advisory Role - Adaptive Biotechnologies (Inst); Amgen (Inst); Bayer (Inst); Bristol Myers Squibb Foundation (Inst); Celgene (Inst); Janssen (Inst); MERCK (Inst); Novartis (Inst); Roche (Inst); SERVIER (Inst); Takeda (Inst)
Research Funding - Amgen (Inst); Bristol Myers Squibb Foundation (Inst); Celgene (Inst); Cellectis (Inst); Janssen (Inst); Novartis (Inst)
 
Katja Weisel
Honoraria - Abbvie; Amgen; AstraZeneca; BeiGene; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen (Inst); Janssen-Cilag; Karyopharm Therapeutics; Novartis; Oncopeptides; Pfizer; Roche; Sanofi; Stemline Therapeutics; Takeda
Consulting or Advisory Role - Abbvie; Amgen; BeiGene; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen-Cilag; Karyopharm Therapeutics; Menarini; Oncopeptides; Regeneron; Roche; Sanofi; Takeda
Research Funding - Abbvie (Inst); Amgen (Inst); Bristol-Myers Squibb/Celgene (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Janssen-Cilag (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen-Cilag; Menarini; Takeda
 
Fredrik Schjesvold
Honoraria - AbbVie; Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Johnson & Johnson; Menarini; Pfizer; Regeneron; Sanofi; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; Galapagos NV; GlaxoSmithKline; Janssen; Johnson & Johnson; Oncopeptides; Pfizer; Sanofi
Expert Testimony - GlaxoSmithKline
 
Joan Blade
Honoraria - Amgen; Celgene; Janssen; Oncopeptides; Takeda
 
Hermann Einsele
No Relationships to Disclose
 
Pieter Sonneveld
Leadership - European Myeloma Network
Consulting or Advisory Role - Amgen; CARsgen Therapeutics; Celgene; Janssen; Karyopharm Therapeutics
Research Funding - Amgen (Inst); BMS (Inst); Janssen (Inst); Skyline Diagnostics (Inst)
 
Mario Boccadoro
Honoraria - AbbVie; Amgen; Bristol Myers Squibb; Celgene; Janssen; Novartis; Sanofi
Consulting or Advisory Role - GlaxoSmithKline; Janssen
Research Funding - Amgen (Inst); Bristol Myers Squibb (Inst); Celgene (Inst); Janssen (Inst); Mundipharma (Inst); Novartis (Inst); Sanofi (Inst)
 
Annemiek Broijl
Honoraria - Amgen; Bristol-Myers Squibb; Janssen; Sanofi
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Janssen; Sanofi